Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma
AP Health Writer WASHINGTON (AP) — Artificial intelligence is changing the way industries do business. But executives in the pharmaceutical industry are still waiting to see whether AI can tackle their biggest challenge: finding faster, cheaper ways to develop new drugs. Despite billions poured into research and development, new medicines still typically take a decade
Continue Reading